01 1Exelon
02 3Exelon/Exelon Patch
03 6Rivastach
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 74
2019 Revenue in Millions : 82
Growth (%) : -9
Main Therapeutic Indication : Neurology
Currency : USD
2021 Revenue in Millions : 24
2020 Revenue in Millions : 71
Growth (%) : -63
Main Therapeutic Indication : Neurology
Currency : USD
2022 Revenue in Millions : 32
2021 Revenue in Millions : 24
Growth (%) : 29
Main Therapeutic Indication : Neuroscience/Mental Health
Currency : USD
2014 Revenue in Millions : -2.20%
2013 Revenue in Millions :
Growth (%) :
Main Therapeutic Indication : Neuroscience and Mental Health
Currency : USD
2015 Revenue in Millions : 1,009
2014 Revenue in Millions : 728
Growth (%) : -28%
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2016 Revenue in Millions : 444
2015 Revenue in Millions : 728
Growth (%) : -39
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2017 Revenue in Millions : 381
2016 Revenue in Millions : 444
Growth (%) : -14
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2017 Revenue in Millions : 87
2016 Revenue in Millions : 82
Growth (%) : 7
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2018 Revenue in Millions : 80
2017 Revenue in Millions : 82
Growth (%) : -2%
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2019 Revenue in Millions : 80
2018 Revenue in Millions : 83
Growth (%) : -3
LOOKING FOR A SUPPLIER?
